In 2025, a landmark study revealed that patients with severe obesity lost an average of 11.9% of their body weight after a year of consistent injectable therapies like semaglutide
Aliabadi and her caring, supportive staff are available to support you through PCOS, endometriosis, menopause, childbirth, infertility, or routine gynecological care
Phase I trial of neoadjuvant dasatinib in patients with resectable malignant pleural mesothelioma
Glucose readings and trend arrows provide information about glucose highs and lows to assist in problem-solving related to meals, physical activity, and illness
Having said that, probably the majority of patients, certainly not all, but a majority of patients who trial a behavioral intervention will fail and need pharmacotherapy
Clinical research highlights these benefits